Please assess the completion status of the following clinical trial:

Trial Title: Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Donors~Exclusion Criteria:~* Important diseases

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 34 Years
- Healthy Volunteers: t

Study Arms:
- Antagonist-hCG for triggering (Type: None): Protocol with antagonist and hCG to trigger oocyte maturation
- Antagonist-aGnRH for triggering (Type: None): Protocol with antagonist and 0,2 mg triptorelin to trigger oocyte maturation
- Long protocol-hCG for triggering (Type: None): Long Protocol and hCG to trigger oocyte maturation

Based on this trial design, predict the completion outcome and termination type (if applicable).